slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 7,081-7,110
Pages 395
Rows per page 30
Slide function
7,081-7,110 of 11,828
39
The slide serves as a milestone marker for the company's public listing.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
08
The chart uses a dual-axis approach to show both per-share metrics and NAV growth over time.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
17
The chart highlights specific periods like the 'Recessionary Period' and 'COVID Pandemic Period' to demonstrate dividend stability.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
18
The chart uses a stacked bar approach to distinguish between monthly and supplemental dividends, with annotations for recessionary and pandemic periods.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
24
LMM stands for Lower Middle Market. The slide uses a mix of bulleted lists to present financial performance and portfolio quality.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
35
The chart uses a combination of bar and line graphs to demonstrate long-term financial performance.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
46
The chart highlights significant market events including the 2008 recessionary period and the COVID-19 pandemic.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
09
The slide uses a 3-column layout to categorize achievements by strategic pillar.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
15
The slide features a thumbnail of a scientific poster presentation.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
18
Includes a highlight box around the primary performance metrics for CRC and AA.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
04
The slide uses a Gantt-style visualization to show the development stage of various programs.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
11
The slide uses a process flow diagram to map clinical outcomes to specific data points.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
12
This is a credibility-building slide showcasing academic validation of the company's technology.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
Focuses on patients who failed or could not tolerate standard azole or IV Amphotericin B therapies.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
21
The slide uses a matrix-like structure to map disease areas (Infection, Inflammation, Oncology) to specific animal models and clinical indications.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
22
Data presented as a multi-panel chart comparing Uninfected, Infected Untreated, SQ Remdesivir, and Oral LNC-Remdesivir groups.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
23
The chart demonstrates high uptake efficiency of LNC-formulated oligos over time across different cell types.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
24
The chart shows dose-dependent inhibition; LNC formulations consistently outperform Taxol.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
26
The chart shows a clear dose-response relationship with increasing efficacy of the LNC formulation at 2.5, 5, and 10 nM doses.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
04
Includes a footer with brand logos and a disclaimer about non-GAAP measures.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
Membership Collective Group | Investor Presentation Deck | 31 slidesMembership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
08
Includes a leadership announcement at the bottom right.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
20
The slide uses a dual-axis approach for each chart, combining bar charts for primary metrics and dot markers for secondary metrics.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Loop · Before After1 hit
22
The slide uses a waterfall chart to explain membership changes and a stacked bar chart to compare national vs company-specific redetermination progress.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations 1 hit
08
The slide uses a grid layout to categorize client work by service line, highlighting deal values and transaction types.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Pitch deck Investor relations Loop · Why Now1 hit
09
Includes an award badge for 'M&A Deal of the Year' from IFR 2022.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Pitch deck Investor relations Loop · Why Now1 hit
10
Includes a hub-and-spoke diagram for service offerings and a league table for 1H 2023.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Pitch deck Investor relations Loop · Why Now1 hit
11
Includes an award badge from The Banker for 2020.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Pitch deck Investor relations Loop · Why Now1 hit
13
Includes a 'Deals of the Year 2022' badge from The Banker.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Pitch deck Investor relations Loop · Why Now1 hit
14
The slide uses a Venn diagram to illustrate the intersection of Products, Sectors, and Regions, surrounded by specific deal examples.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Pitch deck Investor relations Loop · Why Now1 hit